Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics) - Image 1

£43.87

Springer Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Name: Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)
Brand: Springer
Price: 43.87 GBP
Availability: InStock

Public Health

About as cheap as it gets. The only time it was cheaper was 4 months ago.

£44 today · all-time low £44 (Jan 2026) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 138 days • 138 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 138 days • 5 price levels

Days at Price

Current Price

Price Analysis

Most common price: £44 (72 days, 52.2%)

Price range: £44 - £51

Price levels: 5 different prices over 138 days

Description

This book focuses on important decision points and evidence needed for making decisions at these points during the development of a new drug. It takes a holistic approach towards drug development by incorporating explicitly knowledge learned from the earlier part of the development and available historical information into decisions at later stages. In addition, the book shares lessons learned from several select examples published in the literature since the publication of the first edition. The second edition reiterates the need for making evidence-based Go/No Go decisions in drug development discussed in the first edition. It substantially expands several topics that have seen great advances since the publication of the first edition. The most noticeable additions include three adaptive trials conducted in recent years that offer excellent learning opportunities, the use of historical data in the design and analysis of clinical trials, and extending decision criteria tothe cases when the primary endpoint is binary. The examples used to illustrate the additional materials all come from real trials with some post-trial reflections offered by the authors. The book begins with an overview of product development and regulatory approval pathways. It then discusses how to incorporate prior knowledge into study design and decision making at different stages of drug development. Prior knowledge includes information pertaining to historical controls. To assist decision making, the book discusses appropriate metrics and the formulation of go/no-go decisions for progressing a drug candidate to the next development stage. Using the concept of the positive predictive value in the field of diagnostics, the book leads readers to the assessment of the probability that an investigational product is effective given positive study outcomes. Lastly, the book points out common mistakes made by drug developers under the current drug-development paradigm. The book offers useful insights to statisticians, clinicians, regulatory affairs managers and decision-makers in the pharmaceutical industry who have a basic understanding of the drug-development process and the clinical trials conducted to support drug-marketing authorization. The authors provide software codes for select analytical approaches discussed in the book. The book includes enough technical details to allow statisticians to replicate the quantitative illustrations so that they can generate information to facilitate decision-making themselves.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 3030797309
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues > Public Health
Domain: Amazon UK
Release Date: 04 September 2021
Listed Since: 25 May 2021

Barcode

No barcode data available

Springer Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

About as cheap as it gets. The only time it was cheaper was 4 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy

New Drug Development: An Introduction to Clinical Trials: Second Edition

Statistical Issues in Drug Development (Statistics in Practice)

Practical Considerations for Adaptive Trial Design and Implementation (Statistics for Biology and Health)

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)

Statistical Methods in Biomarker and Early Clinical Development

Fundamentals of Drug Development

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

Statistical Methods in Biomarker and Early Clinical Development

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Mastering Strategic Marketing For Specialty Pharmaceuticals: A Hands-on Guide

Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research

Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)

Multiple Testing Problems in Pharmaceutical Statistics: 33 (Chapman & Hall/CRC Biostatistics Series)

Pharmaceutical Statistics: MBSW 39, Muncie, Indiana, USA, May 16-18, 2016: 218 (Springer Proceedings in Mathematics & Statistics, 218)

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Drug Information: A Guide for Pharmacists, Fourth Edition

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)